首页> 外文OA文献 >The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015

【2h】

The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson's disease: a preliminary autoradiographic study with the selective dopamine D2/D3 antagonist [3H]raclopride and the novel CB1 inverse agonist [125I]SD7015

机译：壳核和尾状核中的多巴胺D2 / D3受体密度与帕金森病中CB1大麻素受体水平保持平行：用选择性多巴胺D2 / D3拮抗剂[3H] raclopride和新型CB1反向激动剂进行的初步放射自显影研究[125] sD7015

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Farkas, Szabolcs; Nagy, Katalin; Jia, Zhisheng; Harkány, Tibor; Palkovits, Miklós; Donohue, Sean; Pike, Victor; Halldin, Christer; Máthé, Domokos; Csiba, László; Gulyás, Balázs;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. The decrease of dopamine D 2/D 3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB 1 cannabinoid receptors in Parkinson's disease: A preliminary autoradiographic study with the selective dopamine D 2/D 3 antagonist [ 3H]raclopride and the novel CB 1 inverse agonis [J] . Brain research bulletin . 2012,第6期

机译：帕金森氏病中壳状核和尾状核中多巴胺D 2 / D 3受体密度的下降与CB 1大麻素受体的维持水平平行：使用选择性多巴胺D 2 / D 3拮抗剂[3H]雷氯普利和小说CB 1逆阿戈尼斯
2. Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with (11C)raclopride. [J] . Rinne JO, Laihinen A, Ruottinen H, Journal of the Neurological Sciences: Official Bulletin of the World Federation of Neurology . 1995,第2期

机译：帕金森氏病早期，壳层中多巴胺D2受体的密度增加，但尾状核中的多巴胺D2受体的密度增加：一项使用（11C）雷氯必利的PET研究。
3. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors [J] . Mark J. Millan, Loretta Iob, Jean-Louis Péglion, Psychopharmacology . 2007,第3期

机译：新型D3 / D2 受体激动剂和抗帕金森剂S32504在大鼠中的歧视性刺激特性：抗精神病药，阿立哌唑，比非普鲁，N-去甲基氯氮平和多巴胺D2的选择性拮抗剂对大鼠的衰减作用但不是D3 受体
4. Behavioral pharmacology of dopamine D2 and D3 receptor agonists and antagonists in rats. [D] . Collins, Gregory T. 2008

机译：大鼠多巴胺D2和D3受体激动剂和拮抗剂的行为药理学。
5. The decrease of dopamine D2/D3 receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB1 cannabinoid receptors in Parkinson’s disease: A preliminary autoradiographic study with the selective dopamine D2/D3 antagonist 3Hraclopride and the novel CB1 inverse agonist 125ISD7015 [O] . Szabolcs Farkas, Katalin Nagy, Zhisheng Jia, -1

机译：腐库和核心的多巴胺D2 / D3受体密度降低与帕金森病的维持水平的CB1大麻素受体水平相平行：用选择性多巴胺D2 / D3拮抗剂3H丙烯锌和新型CB1逆激动剂的初步放射性研究125i SD7015
6. In vivo SPECT and ex vivo autoradiographic brain imaging of the novel selective CB1 receptor antagonist radioligand [125I]SD7015 in CB1 knock-out and wildtype mouse [O] . Máthé, Domokos D., Horváth, Ildikó I., Szigeti, Krisztián K., 2013

机译：CB1基因敲除和野生型小鼠中新型选择性CB1受体拮抗剂放射性配体[125I] SD7015的体内SPECT和离体放射自显影脑成像

著录项

引文网络

相似文献

相关主题

期刊订阅